59 results on '"Webb, D. J."'
Search Results
2. Influenza-attributable burden in United Kingdom primary care
3. Aortic dissection in children and adolescents with Turner syndrome: risk factors and management recommendations
4. THE ROLE OF THE CLINICAL PHARMACOLOGIST IN HEALTH TECHNOLOGY APPRAISAL (HTA): S4
5. SUICIDE ATTEMPT IN EPILEPSY: INCIDENCE AND RISK FACTORS: 093
6. Relationship of markers of arterial stiffness to left ventricular hypertrophy and cardiovascular disease in Type 2 diabetes: the Edinburgh Type 2 Diabetes Study (ET2DS): A24 (P29)
7. CYCLOPHILIN A IS A MEDIATOR OF PARACETAMOL-INDUCED LIVER INJURY: O55
8. CHRONIC ENDOTHELIN-A RECEPTOR ANTAGONISM REDUCES PROTEINURIA, BLOOD PRESSURE & ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE: O25
9. EARLY ASSESSMENT OF COST-EFFECTIVENESS: I53
10. Impact of a focussed teaching programme on practical prescribing skills among final year medical students
11. Central obesity is independently associated with arterial stiffness in adults with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study (ET2DS): A45 (P20)
12. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma
13. “Shoot the renals”: the evidence is actually round the corner!
14. Transcendental meditation and hypertension
15. The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?
16. ADHESION SIGNALING THROUGH ACTIN REGULATES THE FORMATION OF DENDRITIC SPINES AND SYNAPSES IN HIPPOCAMPAL NEURONS: C04–01
17. Similarity between the suprasystolic wideband external pulse wave and the first derivative of the intra-arterial pulse wave
18. Plasma endothelin response to acute hypoglycaemia in adults with Type 1 diabetes
19. Clinical trials of endothelin antagonists in heart failure: publication is good for the public health
20. Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial
21. Selectivity of NSAIDs for COX-2 and cardiovascular outcome
22. Pericardial effusions in healthy lowlanders after acute ascent to high altitude
23. Selective endothelin B receptor blockade does not influence BNP-induced natriuresis in man
24. Multiple period resonances in long period gratings in photonic crystal fibres
25. Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure
26. Endothelin antagonism in pulmonary hypertension, heart failure, and beyond
27. Hyperuricaemia does not impair cardiovascular function in healthy adults
28. Acute endothelin A receptor antagonism improves pulmonary and systemic haemodynamics in patients with pulmonary arterial hypertension that is primary or autoimmune and related to congenital heart disease
29. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide
30. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study
31. Central haemodynamic responses to insulin and hypoglycaemia in humans with and without Type 1 diabetes: P152
32. Local nitric oxide release does not affect tachyphylaxis to angiotensin II in dorsal hand veins in man in the presence of prostaglandin synthesis inhibition
33. Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo
34. Activation of the endothelin system in insulin resistance
35. Oceanography: Vertical mixing in the ocean
36. Increased augmentation index and systolic stress in type 1 diabetes mellitus
37. Uric acid as a risk factor for cardiovascular disease
38. Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriography
39. Increased augmentation index and systolic stress in type 1 diabetes mellitus
40. ATHEROMATOUS PLAQUE VOLUME CORRELATES WITH ENDOTHELIUM-DEPENDENT VASODILATATION IN THE HUMAN CORONARY ARTERY
41. TITLE: VASCULAR TONE IN HEALTH AND HEART FAILURE: THE ROLE OF BRADYKININ.
42. Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery
43. COMPARISON BETWEEN ACETYLATED AND NON-ACETYLATED DERIVATIVES OF RIG200.
44. INHIBITION OF HUMAN PLATELET AGGREGATION BY S-NITROSOGLUTATHIONE AND A NOVEL S-NITROSATED GLYCO-AMINO ACID: REVERSAL BY RED BLOOD CELLS AND HAEMOGLOBIN
45. S-NITROSOTHIOLS DO NOT ENGENDER VASCULAR TOLERANCE AND REMAIN EFFECTIVE IN GLYCERYL TRINITRATE-TOLERANT RAT FEMORAL ARTERIES
46. COMPARISON BETWEEN ACETYLATED AND NON-ACETYLATED DERIVATIVES OF RIG200.
47. INHIBITION OF HUMAN PLATELET AGGREGATION BY S-NITROSOGLUTATHIONE AND A NOVEL S-NITROSATED GLYCO-AMINO ACID: REVERSAL BY RED BLOOD CELLS AND HAEMOGLOBIN
48. S-NITROSOTHIOLS DO NOT ENGENDER VASCULAR TOLERANCE AND REMAIN EFFECTIVE IN GLYCERYL TRINITRATE-TOLERANT RAT FEMORAL ARTERIES
49. Clinical pharmacology and therapeutics in a changing world
50. Failure to mount an endothelin response is associated with increased mortality following repair of ruptured abdominal aortic aneurysm
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.